NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
82626 Dehydroepiandrosterone (dhea) hormone level CPT · General Laboratory test
Classification Test › General Laboratory › Clinical Chemistry (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 206,085 services · est. ▲ 14.8% YoY · 23,261 FFS beneficiaries (CY2024, all-Medicare estimate) — 102,789 observed fee-for-service services
Medicare paid $5.1M · est. · $24.75 avg / service, national — $2.5M observed FFS
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups

7

Named groups billing this code
Named-group all-Medicare svcs · est.

78,052

Scaled from 38,930 observed FFS services.
FFS of Medicare

49%

Payer-mix frame
Services · year over year
Services YoY

+14.8%

All-Medicare est. · observed FFS +10.8%
Volume, not care. A shrinking fee-for-service denominator is not a shrinking market.
Estimated all-Medicare volume estimate
FFS + estimated MA

~78,052 services

38,930 observed fee-for-service (50%) · ~39,122 estimated Medicare Advantage.

Billing for this code concentrates in one state — scaled by the national payer mix (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale
Top states — 82626 (CY2024)
AZ 157,546 TX 9,155 NC 8,977 FL 8,056 NJ 5,841

Est. all-Medicare services by billing state (scaled estimate — assumes MA utilization mirrors FFS); open a bar for that state's ranked market.

Billed → allowed → paid
Named-group submitted charges
$1.6M
Named-group allowed amount
$964K
Named-group Medicare payments
$1.9M · est.
— $964K observed FFS
Avg charge / svc
$41
Avg allowed / svc
$25
Avg payment / svc
$25
Totals are named-group (attributable) sums. Allowed is Medicare’s fee-schedule recognized price — what CMS recognizes, before the 80% Medicare pays.
Average charge per group
$39 7 groups · avg submitted charge / service $131
Market analyticsPlatform Methods →

Search a single state to see that market's full analytics — the free tier previews every panel, gated.

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →
Unlock the Platform — the full read, every number below, code baskets, and export. Looking is free; the depth is paid. Notify me at launch →
Refine: group size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022  CY2021  CY2020 
# Physician group City St Specialty Providers 82626 svcs Submitted charges Avg charge Medicare $ Share of state* Phone
1 YUMA KIDNEY AND DIALYSIS SPECIALISTS PC YUMA AZ NURSE PRACTITIONER 6 37,371 $1,457,469 $39 47.7% (928) 388-6138
2 LEGACY HEALTHCARE SERVICES INC DURHAM FL INTERNAL MEDICINE 3859 815 $76,610 $94 23.1% (919) 419-9600
3 EDWARD CONDON MEDICAL PC COMMACK NY ENDOCRINOLOGY 2 448 $32,256 $72 32.0% (631) 462-2200
4 NAUSHIN SIDDIQUI PHYSICIAN PC EAST MEADOW NY INTERNAL MEDICINE 2 198 $8,910 $45 14.1% (516) 481-2000
5 AMERICAN MEDICAL TODAY PC BROOKLYN NY INTERNAL MEDICINE 10 57 $2,850 $50 4.1% (718) 306-5025
That's the top 5 of 7 groups. The platform ranks the whole market — code baskets, benchmarks, and the full ranked list. the full ranking is part of the market analytics platform — built, not launched yet. Notify me at launch →

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix — and the observed foundation every market figure here builds on. Market totals anchor on a labeled all-Medicare estimate scaled from that foundation, with the observed count disclosed beside it — Medicare only, never all-payer. Modeled all-payer databases project every payer statistically and typically run higher. Same market, different denominator. How the numbers reconcile →